CVS HEALTH Corp (CVS) Earnings
CVS HEALTH Corp's most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Aug 5, 2026
From the latest earnings 8-K
Revenue · FY2025
$402.07B
▲ 7.8%YoY
Diluted EPS · FY2025
$1.39
▼ 62.0%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from CVS's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $402.07B | $1.73B | — | $1.39 | $7.81B | 1.2% | +7.8% |
| FY2024 | $372.81B | $4.59B | — | $3.66 | $6.33B | 2.3% | +4.2% |
| FY2023 | $357.78B | $8.37B | — | $6.47 | $10.39B | 3.8% | +10.9% |
| FY2022 | $322.47B | $4.17B | — | $3.14 | $13.45B | 2.4% | +10.4% |
Recent earnings filings
| Filed | Form | Accession |
|---|---|---|
| Aug 5, 2026 | 8-K (2.02) | 0000064803-26-000097EDGAR |
| May 6, 2026 | 8-K (2.02) | 0000064803-26-000051EDGAR |
| Feb 10, 2026 | 8-K (2.02) | 0000064803-26-000009EDGAR |
| Oct 29, 2025 | 8-K (2.02) | 0000064803-25-000036EDGAR |
| Jul 31, 2025 | 8-K (2.02) | 0000064803-25-000023EDGAR |
| May 1, 2025 | 8-K (2.02) | 0000064803-25-000012EDGAR |
| Feb 12, 2025 | 8-K (2.02) | 0000064803-25-000006EDGAR |
| Nov 6, 2024 | 8-K (2.02) | 0000064803-24-000033EDGAR |
Earnings for companies related to CVS
Never miss a CVS filing.
Get an email when CVS files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Sep 15, 2026Source: SEC EDGAR.